Green Nanoemulsion Stabilized by In Situ Self-Assembled Natural Oil/Native Cyclodextrin Complexes: An Eco-Friendly Approach for Enhancing Anticancer Activity of Costunolide Against Lung Cancer Cells

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2022 Feb 26

PMID 35213960

Authors

Nabil A Alhakamy

Shaimaa M Badr-Eldin

Osama A A Ahmed

Hibah M Aldawsari

Solomon Z Okbazghi

Mohamed A Alfaleh

Wesam H Abdulaal

Thikryat Neamatallah

Omar D Al-Hejaili

Usama A Fahmy

Affiliations

Soon will be listed here.

Abstract

Lung cancer is the second-most deadly malignancy worldwide, of which smoking is considered a major risk factor and causes 75-80% of lung cancer-related deaths. Costunolide (CTD) extracted from plant species exhibits potent anticancer properties, specifically in lung cancer and leukemia. Several nanoemulsions were prepared and optimized using a three-factor Box-Behnken experimental design. The optimized green nanoemulsion (GNE) showed a vesicle size of 199.56 nm. The IC values revealed that A549 cells were significantly more sensitive to the optimized CTD formula than the plain formula and raw CTD. A cell cycle analysis revealed that the optimized CTD formula treatment resulted in significant cell cycle arrest at the S phase. The results also indicated that treatment with the CTD formula significantly increased caspase-3, Bax, Bcl-2, and p53 mRNA expression compared to the plain formula and CTD raw. In terms of the inflammatory markers, the optimized formula significantly reduced the activity of TNF-α and NF-κB in comparison with the plain formula and raw drug only. Overall, the findings from the study proved that a CTD GNE formulation could be a promising therapeutic approach for the treatment of lung cancer.

Citing Articles

Correction: Alhakamy et al. Green Nanoemulsion Stabilized by In Situ Self-Assembled Natural Oil/Native Cyclodextrin Complexes: An Eco-Friendly Approach for Enhancing Anticancer Activity of Costunolide against Lung Cancer Cells. 2022, , 227.

Alhakamy N, Badr-Eldin S, Ahmed O, Aldawsari H, Okbazghi S, Alfaleh M Pharmaceutics. 2025; 17(1.

PMID: 39861788 PMC: 11768223. DOI: 10.3390/pharmaceutics17010107.

Self-assembled nanoparticles of costunolide and glycyrrhizic acid for enhanced ulcerative colitis treatment.

Fu H, Zheng X, Xu K, Zhang Y, Wu M, Xu M BMC Gastroenterol. 2024; 24(1):223.

PMID: 38992591 PMC: 11241987. DOI: 10.1186/s12876-024-03313-9.

Recent Advances in Nanotechnology-Based Targeted Delivery Systems of Active Constituents in Natural Medicines for Cancer Treatment.

Hu Y, Song J, Feng A, Li J, Li M, Shi Y Molecules. 2023; 28(23).

PMID: 38067497 PMC: 10708032. DOI: 10.3390/molecules28237767.

Design, synthesis, antitumor evaluation, and molecular docking of novel pyrrolo[2,3-d]pyrimidine as multi-kinase inhibitors.

Alanazi A, Mirgany T, Alsaif N, Alsfouk A, Alanazi M Saudi Pharm J. 2023; 31(6):989-997.

PMID: 37234342 PMC: 10205775. DOI: 10.1016/j.jsps.2023.05.003.

Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems.

Jampilek J, Kralova K Pharmaceutics. 2022; 14(12).

PMID: 36559176 PMC: 9781429. DOI: 10.3390/pharmaceutics14122681.

References

Alfaifi M, Shati A, Elbehairi S, Fahmy U, Alhakamy N, Md S . Anti-tumor effect of PEG-coated PLGA nanoparticles of febuxostat on A549 non-small cell lung cancer cells. 3 Biotech. 2020; 10(3):133. PMC: 7036082. DOI: 10.1007/s13205-020-2077-x. View

Kaur K, Kumar R, Arpita , Goel S, Uppal S, Bhatia A . Physiochemical and cytotoxicity study of TPGS stabilized nanoemulsion designed by ultrasonication method. Ultrason Sonochem. 2016; 34:173-182. DOI: 10.1016/j.ultsonch.2016.05.037. View

Jug M, Yoon B, Jackman J . Cyclodextrin-based Pickering emulsions: functional properties and drug delivery applications. J Incl Phenom Macrocycl Chem. 2021; 101(1-2):31-50. PMC: 8330820. DOI: 10.1007/s10847-021-01097-z. View

Mattiuzzi C, Lippi G . Current Cancer Epidemiology. J Epidemiol Glob Health. 2019; 9(4):217-222. PMC: 7310786. DOI: 10.2991/jegh.k.191008.001. View

Long Y, Huang W, Wang Q, Yang G . Green synthesis of garlic oil nanoemulsion using ultrasonication technique and its mechanism of antifungal action against Penicillium italicum. Ultrason Sonochem. 2020; 64:104970. DOI: 10.1016/j.ultsonch.2020.104970. View

Caruso G, Distefano D, Parlascino P, Fresta C, Lazzarino G, Lunte S . Receptor-mediated toxicity of human amylin fragment aggregated by short- and long-term incubations with copper ions. Mol Cell Biochem. 2016; 425(1-2):85-93. DOI: 10.1007/s11010-016-2864-1. View

Inoue M, Hashizaki K, Taguchi H, Saito Y . Formation and characterization of emulsions using beta-cyclodextrin as an emulsifier. Chem Pharm Bull (Tokyo). 2008; 56(5):668-71. DOI: 10.1248/cpb.56.668. View

Yingchoncharoen P, Kalinowski D, Richardson D . Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come. Pharmacol Rev. 2016; 68(3):701-87. PMC: 4931871. DOI: 10.1124/pr.115.012070. View

Herbst R, Morgensztern D, Boshoff C . The biology and management of non-small cell lung cancer. Nature. 2018; 553(7689):446-454. DOI: 10.1038/nature25183. View

10.

Lortet-Tieulent J, Soerjomataram I, Ferlay J, Rutherford M, Weiderpass E, Bray F . International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women. Lung Cancer. 2014; 84(1):13-22. DOI: 10.1016/j.lungcan.2014.01.009. View

11.

Lam W, White N, Chan-Yeung M . Lung cancer epidemiology and risk factors in Asia and Africa. Int J Tuberc Lung Dis. 2004; 8(9):1045-57. View

12.

Badr-Eldin S, Aldawsari H, Ahmed O, Alhakamy N, Neamatallah T, Okbazghi S . Optimized semisolid self-nanoemulsifying system based on glyceryl behenate: A potential nanoplatform for enhancing antitumor activity of raloxifene hydrochloride in MCF-7 human breast cancer cells. Int J Pharm. 2021; 600:120493. DOI: 10.1016/j.ijpharm.2021.120493. View

13.

Li J, Yuan J . Caspases in apoptosis and beyond. Oncogene. 2008; 27(48):6194-206. DOI: 10.1038/onc.2008.297. View

14.

Singh B, Bhatowa R, Tripathi C, Kapil R . Developing micro-/nanoparticulate drug delivery systems using "design of experiments". Int J Pharm Investig. 2012; 1(2):75-87. PMC: 3465123. DOI: 10.4103/2230-973X.82395. View

15.

Duma N, Santana-Davila R, Molina J . Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment. Mayo Clin Proc. 2019; 94(8):1623-1640. DOI: 10.1016/j.mayocp.2019.01.013. View

16.

Badr-Eldin S, Labib G, Aburahma M . Eco-Friendly Tadalafil Surfactant-Free Dry Emulsion Tablets (SFDETs) Stabilized by In Situ Self-Assembled Aggregates of Natural Oil and Native Cyclodextrins. AAPS PharmSciTech. 2019; 20(7):255. DOI: 10.1208/s12249-019-1450-8. View

17.

Wisnivesky J, de-Torres J . The Global Burden of Pulmonary Diseases: Most Prevalent Problems and Opportunities for Improvement. Ann Glob Health. 2019; 85(1). PMC: 7052315. DOI: 10.5334/aogh.2411. View

17.

Sardeli C, Zarogoulidis P, Kosmidis C, Amaniti A, Katsaounis A, Giannakidis D . Inhaled chemotherapy adverse effects: mechanisms and protection methods. Lung Cancer Manag. 2020; 8(4):LMT19. PMC: 6978726. DOI: 10.2217/lmt-2019-0007. View

18.

Farnebo M, Bykov V, Wiman K . The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer. Biochem Biophys Res Commun. 2010; 396(1):85-9. DOI: 10.1016/j.bbrc.2010.02.152. View

19.

Hu M, Liu L, Yao W . Activation of p53 by costunolide blocks glutaminolysis and inhibits proliferation in human colorectal cancer cells. Gene. 2018; 678:261-269. DOI: 10.1016/j.gene.2018.08.048. View